INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Cancer Risk Reduction desk →

1,241 studies · page 29 of 52

2020 / Narrative review

Nicotinamide is reviewed as a low-cost, safe, evidence-based treatment for skin cancers, actinic keratosis, and bullous pemphigoid.

This review discusses nicotinamide (niacinamide), a form of vitamin B3 often confused with nicotinic acid (niacin). The authors examine its evidence as a low-cost oral treatment option for actinic keratosis, squamous cell carcinomas, basal cell carcinomas, and bullous pemphigoid. It details nicotinamide's favorable safety profile, distinguishes it from niacin, and addresses barriers to its integration into clinical practice along with practical guidance on recommendations and product availability.

Huber R, Wong A Skin Therapy Lett, 2020. PMID 33196157

2019 / Narrative review

A review reports that about 130 human clinical trials of resveratrol have yielded varying results, alongside a pristine safety profile.

This narrative review discusses the history and development of resveratrol research. Around 130 human clinical trials have been conducted or are underway with varying results, potentially due to disparate doses ranging from approximately 5 to 5,000 mg/day and variable experimental settings. Molecular targets are numerous without a dominant mechanism, but resveratrol maintains a pristine safety profile and widespread use as a dietary supplement. The author suggests future investigation is warranted, noting potential promise for topical preparations and conditions responsive to anti-inflammatory action or direct exposure, such as colon cancer prevention.

Pezzuto JM Biomol Ther (Seoul), 2019. PMID 30332889

2019 / Narrative review of two prospective cohort studies

In AHS-2 and EPIC-Oxford cohorts, vegetarian diets were linked to lower cancer and mortality risks and substantially reduced greenhouse gas emissions.

Researchers reviewed publications from the AHS-2 and EPIC-Oxford cohorts to describe the dietary intakes, health effects, and environmental outcomes of vegetarian patterns. In AHS-2, vegans had a 16% reduced risk of all cancers, while vegans, vegetarians, and fish-eaters in EPIC-Oxford showed an 11-19% lower risk compared to non-vegetarians. Pesco-vegetarians in AHS-2 had significantly lower all-cause and ischemic heart disease mortality, and EPIC-Oxford fish-eaters had significantly lower all-cancer mortality versus non-vegetarians. Greenhouse gas emissions of equicaloric diets were 29% lower for vegetarian diets in AHS-2 and 47-60% lower for vegetarian/vegan diets in EPIC-Oxford compared to non-vegetarian/meat-eating diets.

Shows an association, not proof of cause and effect.

Segovia-Siapco G, Sabaté J Eur J Clin Nutr, 2019. PMID 30487555

2019 / Conference proceedings summary

Personalized nutrition approaches like carbohydrate restriction and short-term fasting may disrupt tumor metabolism and enhance cancer therapies.

This conference proceedings manuscript summarizes findings from the 2017 American College of Nutrition Annual Meeting focused on personalized nutrition in cancer. Approximately 20% of all cancers diagnosed in the United States are attributable to unhealthy diet, excessive alcohol consumption, physical inactivity, and body fatness. Increasing evidence indicates that standard dietary recommendations may not be appropriate after diagnosis, whereas interventions such as short-term fasting and carbohydrate restriction can disrupt tumor metabolism and potentially synergize with radiation and drug therapy.

Wallace TC, Bultman S, D'Adamo C, et al. J Am Coll Nutr, 2019. PMID 30511901

2019 / Clinical review of clinical trials

A review of 77 clinical studies highlights the lipid-lowering and insulin-resistance improving effects of berberine with low toxicity.

This review examined clinical trials on Berberis vulgaris and its alkaloid constituent berberine across electronic databases. Across 77 human clinical studies, lipid-lowering and insulin-resistance improving actions were the most frequently studied properties, alongside cardiovascular, anticancer, gastrointestinal, CNS, and endocrine applications. Berberine demonstrated very low toxicity at usual doses with no major side effects, though mild gastrointestinal reactions occurred in some patients.

Imenshahidi M, Hosseinzadeh H Phytother Res, 2019. PMID 30637820

2019 / Narrative review

Meeting or exceeding recommended physical activity levels supports longevity, with maximal benefits seen at three to five times the minimum recommendations.

This review examined recent evidence regarding the dose and type of physical activity that promotes longevity and disease-free aging. Meeting at least 150 minutes per week of moderate-intensity leisure time aerobic activity provides most longevity benefits, while higher duration and intensity augment cardiovascular and metabolic effects. Performing three to five times the minimum recommended physical activity achieves maximal longevity benefit, though benefit may decrease with even higher amounts. High maximal oxygen uptake in mid-life serves as a strong marker of longevity, and muscle mass is a critical prognostic factor in aging and cancer.

Pedersen BK Curr Opin Clin Nutr Metab Care, 2019. PMID 30640736

2019 / Narrative review

Nicotinamide reduces transepidermal water loss and new non-melanoma skin cancers in high-risk humans.

This review examines the dermatologic roles of nicotinamide, a water-soluble vitamin B3 derivative, specifically for preventing photoaging and skin cancers. Nicotinamide prevents UV-induced ATP depletion and glycolysis inhibition, thereby enhancing DNA repair and lowering UV-induced immune suppression. Randomized controlled clinical trials noted in the review demonstrate that nicotinamide decreases transepidermal water loss and the occurrence of new non-melanoma skin cancers in high-risk humans.

Snaidr VA, Damian DL, Halliday GM Exp Dermatol, 2019. PMID 30698874

2019 / Narrative review of clinical trials

Resveratrol shows therapeutic potential across various diseases in over 244 clinical trials and is reported safe at doses up to 5 g/day.

This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.

Singh AP, Singh R, Verma SS, et al. Med Res Rev, 2019. PMID 30741437

2019 / Policy review and legal feasibility analysis

US policies to lower processed meat intake are largely legally feasible, though political feasibility is influenced by industry power.

Authors reviewed the scientific literature on meat intake and cancer risk alongside the legal and political feasibility of four US policy options to reduce processed meat consumption. The World Health Organization previously estimated that each 50-gram increase in daily processed meat intake raises colorectal cancer risk by 18%. Legal feasibility was found to be highest for taxation, reducing processed meat in school meals and nutrition programs, and public service announcements, while warning labels had moderate feasibility due to evidentiary legal questions. Political feasibility remains constrained by meat industry influence and forthcoming Dietary Guidelines decisions.

Wilde P, Pomeranz JL, Lizewski LJ, et al. Milbank Q, 2019. PMID 31016816

2019 / Review

Short-term fasting is safe but challenging in cancer patients receiving chemotherapy, while efficacy trials remain in their infancy.

This review summarizes preclinical and clinical evidence on the molecular mechanisms and effects of short-term fasting (STF) alongside cancer chemotherapy. Preclinical data show STF enhances the efficacy of various chemotherapeutic agents and protects healthy cells from toxicity. In humans, preliminary findings suggest STF is safe but challenging for cancer patients receiving chemotherapy, with clinical research still in its infancy.

de Groot S, Pijl H, van der Hoeven JJM, et al. J Exp Clin Cancer Res, 2019. PMID 31113478

2019 / Review of the literature

A literature review found a relationship between milk product consumption and prostate cancer progression, along with a possible link to initiation.

This review examined potential associations between high milk and dairy intake and prostate cancer (PC). Searches covering dairy intake, PC incidence, and mTORC1 signaling yielded 32 reviews, of which 21 were analyzed. The authors noted no studies show an unequivocal relationship between milk products and PC initiation or progression, and direct evidence linking dairy, PC, and mTORC1 signaling remains scarce. However, persistent mTORC1 hyper-activation is linked to PC promotion, and the authors concluded a relationship can be established between milk product consumption and PC progression, alongside a possible association with PC initiation.

Shows an association, not proof of cause and effect.

Vasconcelos A, Santos T, Ravasco P, et al. Front Nutr, 2019. PMID 31139629

2019 / Narrative review

A 2% absolute increase in energy intake from trans fats is associated with a 23% increase in cardiovascular risk, alongside increased cancer and diabetes risk.

A review of epidemiologic and biochemical evidence evaluated trans fatty acid (TFA) intake and chronic disease risks. A 2% absolute increase in energy intake from trans fat has been associated with a 23% increase in cardiovascular risk. TFAs increase low-density lipoprotein levels, and several epidemiological studies demonstrate that high TFA intake increases the incidence of cancer and diabetes. Complete elimination of TFAs is not possible in a balanced diet due to their natural presence in dairy and meat products.

Shows an association, not proof of cause and effect.

Islam MA, Amin MN, Siddiqui SA, et al. Diabetes Metab Syndr, 2019. PMID 31336535

2019 / Expert consensus statement and narrative review

An expert consensus concluded that moderate palm oil intake in a healthy diet presents no health risks and lacks evidence linking it to human cancer risk.

Spanish experts in food industry, nutrition, toxicology, sustainability, and veterinary science convened to evaluate scientific evidence regarding palm oil as a food ingredient. The consensus concluded that moderate intake of palm oil within a healthy diet presents no risks for health, and no evidence justifies changing fat intake recommendations. Additionally, no evidence was found associating palm oil consumption with higher cancer risk, incidence, or mortality in humans. Tolerable daily intakes for toxic processing contaminants have been established by JECFA and EFSA, leading to updated European Commission regulations.

NANO counterpoint →

Gesteiro E, Guijarro L, Sánchez-Muniz FJ, et al. Nutrients, 2019. PMID 31454938

2019 / Narrative review

Nutraceuticals, medicinal plants, and antioxidant-rich diets show potential roles in managing or preventing benign and malignant prostate diseases.

This review summarizes evidence for nutraceuticals and medicinal plants in treating and preventing prostate diseases. Epidemiological studies link the Mediterranean diet, high fruit and vegetable consumption, lycopene, and zinc with protection against prostate cancer or benign prostatic hyperplasia (BPH). Meta-analyses indicate Serenoa repens is more effective than placebo for mild to moderate lower urinary tract symptoms, while agents like lycopene, selenium, pollen extract, and beta-sitosterol also demonstrate symptomatic improvements in BPH or chronic pelvic pain syndrome.

Cicero AFG, Allkanjari O, Busetto GM, et al. Arch Ital Urol Androl, 2019. PMID 31577095

2019 / Narrative review

Colorectal cancer incidence is rising globally, with lifestyle factors like obesity and red meat consumption identified as key drivers.

This review evaluates global colorectal cancer (CRC) epidemiology using GLOBOCAN 2018 data. In 2018, nearly 2 million new cases and about 1 million deaths were expected, making CRC the third most deadly and fourth most commonly diagnosed cancer worldwide. Rising incidence, especially in developing nations, is attributed to factors including obesity, sedentary lifestyle, red meat consumption, alcohol, and tobacco. Mortality has declined in developed nations due to screening and treatment advances, and risk reduction is noted through lower intake of red meat, alcohol, and tobacco alongside higher consumption of fibre, wholesome foods, vitamins, and minerals.

Shows an association, not proof of cause and effect.

Rawla P, Sunkara T, Barsouk A Prz Gastroenterol, 2019. PMID 31616522

2019 / Literature review

A review of 47 studies linked plant-based foods to lower or unchanged prostate cancer risk, while dairy was linked to higher or unchanged risk.

This review investigated the association of plant- and animal-based food consumption with prostate cancer risk using studies published between 2006 and February 2017. A total of 47 studies were eligible, including 29 cohort studies, 13 case-control studies, 4 meta-analyses, and 1 population study. Most studies showed that plant-based foods were linked to either decreased or unchanged risk of prostate cancer. In contrast, animal-based foods, particularly dairy products, were linked to either increased or unchanged risk of prostate cancer.

Shows an association, not proof of cause and effect.

Shin J, Millstine D, Ruddy B, et al. J Am Osteopath Assoc, 2019. PMID 31633743

2019 / Narrative review

Healthy plant-based diets are linked to lower risks of obesity, type 2 diabetes, cardiovascular disease, and certain cancers compared with Western diets.

This review discusses the intertwined burdens of diet-related chronic diseases and environmental degradation caused by current global dietary patterns and food systems. Shifting toward healthy plant-based diets, compared with typical Western diets high in animal products, has been associated with lower risks of obesity, type 2 diabetes, cardiovascular disease, and some cancers, while also improving sustainability. While precision nutrition may offer tailored disease prevention, it is in its early stages and not ready for widespread clinical use, underscoring the ongoing importance of broader public health nutrition strategies.

Shows an association, not proof of cause and effect.

Hemler EC, Hu FB Adv Nutr, 2019. PMID 31728495

2019 / Narrative review

A review suggests plant-based diets may reduce the risk of heart disease and possibly cancer among Black individuals in the United States.

This review evaluated the evidence on plant-based diets and health outcomes, examining how these benefits translate to Black individuals in the United States. Although substantial evidence supports plant-based diets in the general population, little research has focused specifically on Black populations. Available data suggest that plant-based diets may reduce the risk of heart disease and possibly cancer in this group. The authors note that more research is needed on cardiovascular risk factors, cancer subtypes, and other chronic diseases, emphasizing the need for culturally appropriate interventions.

Shows an association, not proof of cause and effect.

Sterling SR, Bowen SA Nutrients, 2019. PMID 31810250

2019 / Literature review

A review suggests that bovine leukemia virus infection from cattle could be a risk factor for human breast cancer.

This literature review summarized and evaluated published research examining the association between bovine leukemia virus (BLV) infection in humans and breast cancer. While noting that the review does not provide absolute proof of causation, the authors suggest that BLV infection could be a breast cancer risk factor based on epidemiologic criteria. They highlight that cattle may act as an environmental reservoir for infectious BLV, presenting opportunities to reduce transmission to humans.

Shows an association, not proof of cause and effect.

Buehring GC, Sans HM Int J Environ Res Public Health, 2019. PMID 31892207

2018 / Narrative review / commentary

A healthy lifestyle including diet could prevent approximately 80% of chronic disease and premature death.

This article discusses the role of lifestyle choices in health and chronic disease prevention. It notes that approximately 80% of chronic disease and premature death could be prevented by avoiding smoking, engaging in physical activity, and following a healthful dietary pattern. Cardiovascular disease, diabetes, stroke, dementia, and cancer are all influenced by lifestyle. The author argues for a global coalition of experts to clarify confusing nutrition messages and promote health-promoting diet and lifestyle patterns.

Katz DL, Frates EP, Bonnet JP, et al. Am J Health Promot, 2018. PMID 28523941

2018 / Narrative review

Elevated cholesterol is linked to breast cancer risk and poor prognosis, while cholesterol-lowering medication appears protective against recurrence.

This review examines clinical and preclinical data on the role of cholesterol and its metabolite, 27-hydroxycholesterol (27-OHC), in breast cancer pathophysiology. Cholesterol has emerged as a risk factor for breast cancer onset, and elevated cholesterol is associated with poor prognosis. While cholesterol-lowering medication is not associated with breast cancer risk, it appears protective against recurrence.

Shows an association, not proof of cause and effect.

Nelson ER Mol Cell Endocrinol, 2018. PMID 28919300

2018 / Narrative review

Lifestyle medicine addressing nutrition and activity is advocated to prevent and manage chronic illnesses like cardiovascular disease, cancer, and diabetes.

This review describes the practice of lifestyle medicine and its impact on chronic diseases such as cardiovascular disease, cancer, and type 2 diabetes. The authors highlight that most chronic illnesses stem from poor nutrition and physical inactivity. They discuss the economic benefits of prevention-based lifestyle medicine and argue that it should become the primary approach to managing and preventing chronic conditions.

Bodai BI, Nakata TE, Wong WT, et al. Perm J, 2018. PMID 29035175

2018 / Narrative review

A review outlines mechanisms linking obesity to cancer and explores dietary strategies like calorie restriction and fasting to reduce cancer burden.

This narrative review discusses the mechanisms connecting obesity to cancer development and progression, noting that obese cancer patients often have poorer prognoses, chemotherapy resistance, and higher rates of distant metastases compared to normal-weight patients. Alterations in systemic metabolism, adipose inflammation, growth factor signaling, and angiogenesis serve as primary drivers of these cancers. The review highlights dietary interventions currently implemented in preclinical and clinical trials, including calorie restriction, intermittent fasting, low-fat diets, and ketogenic diets, to reduce the incidence and progression of obesity-related cancers.

Smith LA, O'Flanagan CH, Bowers LW, et al. J Acad Nutr Diet, 2018. PMID 29102513

2018 / Narrative review

Evidence suggests dietary factors and nutrition play roles in cancer prevention and influencing treatment outcomes.

This review considers implications from human, animal, and in-vitro studies regarding dietary factors in cancer. The China Project found a significant correlation between disease incidence and markers of animal product consumption, while animal studies show animal protein promotes cancer. In both human and animal studies, food restriction has been shown to slow cancer progression, and phytochemicals from whole plant foods demonstrate several protective anti-cancer mechanisms. The authors note that new research methodologies must be developed since drug-study strategies are not appropriate for studying diet effects.

Logan J, Bourassa MW Eur J Cancer Prev, 2018. PMID 29461280